Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Advertisement
GAM ID: header
Article
Page 61
Posts about this type
JCP
Article
Immediate-Release Versus Controlled-Release Formulations: Pharmacokinetics of Newer Antidepressants in Relation to Nausea
December 1, 2003
C. Lindsay DeVane
JCP
Article
Improving Antidepressant Adherence
December 1, 2003
Charles B. Nemeroff
JCP
Article
Intramuscular Ziprasidone: Moving Beyond the Conventional in the Treatment of Acute Agitation in Schizophrenia
December 1, 2003
Shlomo Brook
JCP
Article
Introduction. Ziprasidone in Schizophrenia: From Acute Treatment to Long-Term Management
December 1, 2003
John M. Kane
JCP
Article
Long-Term Side Effects of SSRIs: Sexual Dysfunction and Weight Gain
December 1, 2003
Robert M. A. Hirschfeld
JCP
Article
Maintaining Symptom Control: Review of Ziprasidone Long-Term Efficacy Data
December 1, 2003
Nina R. Schooler
JCP
Article
Oral Ziprasidone in the Treatment of Schizophrenia: A Review of Short-Term Trials
December 1, 2003
John M. Kane
JCP
Article
Potential New Drug Delivery Systems for Antidepressants: An Overview
December 1, 2003
Clinton D. Kilts
JCP
Article
The Psychopharmacology of Ziprasidone: Receptor-Binding Properties and Real-World Psychiatric Practice
December 1, 2003
Stephen M. Stahl
,
Darius K. Shayegan
JCP
Article
Special Issues Related to the Treatment of Depression in Women
December 1, 2003
Kimberly A. Yonkers
JCP
Article
Tolerability of Ziprasidone: An Expanding Perspective
December 1, 2003
David G. Daniel
JCP
Article
Ziprasidone and Cognition: The Evolving Story
December 1, 2003
Philip D. Harvey
PCC
Article
Emerging Therapeutic Strategies for Treating Alzheimer's Disease in Primary Care
December 1, 2003
JCP
Article
Choice of Maintenance Medication for Schizophrenia
November 1, 2003
John M. Davis
,
Nancy Chen
JCP
Article
Clinical Guidelines: Dosing and Switching Strategies for Long-Acting Risperidone
November 1, 2003
Stephen R. Marder
,
Robert Conley
,
Larry Ereshefsky
, et al
JCP
Article
Advocacy Perspective
November 1, 2003
Michael J. Fitzpatrick
JCP
Article
Government Perspective
November 1, 2003
Joseph J. Parks
JCP
Article
Health Care Organization Perspective
November 1, 2003
William Goldman
JCP
Article
Purchasing Community Perspective
November 1, 2003
Marsha C. Moore
JCP
Article
Comparison of the Effects of Different Routes of Antipsychotic Administration on Pharmacokinetics and Pharmacodynamics
November 1, 2003
Larry Ereshefsky
,
Cynthia A. Mascarenas
JCP
Article
The Economic and Human Impact of New Drugs
November 1, 2003
Frank R. Lichtenberg
JCP
Article
Efficacy and Effectiveness of First- and Second-Generation Antipsychotics in Schizophrenia
November 1, 2003
Ari B. Jaffe
,
Jerome Levine
JCP
Article
Factors Influencing Compliance in Schizophrenia Patients
November 1, 2003
W. Wolfgang Fleischhacker
,
Maria A. Oehl
,
Martina Hummer
JCP
Article
Impact of Formularies on Clinical Innovation
November 1, 2003
Frederick K. Goodwin
«
1
…
59
60
61
62
63
…
107
»
